Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Hydroxyurea). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
ইঙ্গিত ও ব্যবহার
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Polycythaemia Vera: Administer 15-20 mg/kg orally once daily.Essential Thrombocythemia: Administer 15 mg/kg orally once daily.Solid Tumors- Intermittent Therapy: Administer 80 mg/kg orally every three days. Continuous Therapy: Administer 20-30 mg/kg orally once daily (qDay)Head & Neck Tumors: Start 80 mg/kg orally every three days (q3days) seven days before initiating irradiation.Chronic Myelocytic Leukemia, Resistant: Administer 20-40 mg/kg orally once daily.Sickle Cell Disease: Initiate at 15 mg/kg/day as a single dose; monitor blood cell counts every two weeks. Titrate by 5 mg/kg/day every 12 weeks, but do not exceed 35 mg/kg/day.
পার্শ্বপ্রতিক্রিয়া
Fever, feeling very tired, chills, shortness of breath, body aches, and bleeding or unexplained bruising.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Myelosuppression: Hydrea causes severe myelosuppression. Treatment with Hydrea should not be started if bone marrow function is markedly depressed. Bone marrow suppression may occur, and leukopenia is generally its first and most common sign. Some patients treated at the recommended initial dose of 15 mg/kg/day have experienced severe or life-threatening myelosuppression. Malignancies: Hydrea is a human carcinogen. Secondary leukemia has been reported in patients receiving long-term Hydrea for myeloproliferative disorders. Skin cancer has also been reported in patients receiving long-term Hydrea. Advise patients to protect themselves from sun exposure and monitor for the development of secondary malignancies. Embryo-Fetal Toxicity: Based on its mechanism of action and findings in animals, Hydrea can cause fetal harm when given to a pregnant woman.
নিষেধাজ্ঞা
Hydroxyurea must not be used in patients who have previously shown hypersensitivity to hydroxyurea or to any other ingredient of the formulation.